LONDON—A case report in The Lancet has highlighted the threat of fake drugs for malaria — the subject of intensive research at the London School of Hygiene & Tropical Medicine. Dr Harparkash Kaur told Peter Goodwin what her laboratory is doing about the global threat of counterfeit drugs, and what happened in the recent case of the patient with malaria in Spain who had been taking anti-malarial drugs purchased in Equatorial Guinea.
You may also like...
Reduce Maternal Deaths! 25 Oct, 2007 Audio Journal of Global Health Issues: Chloroquine for Malaria: Could It Make a Comeback? 6 Dec, 2006 Dengue Fever: Vaccines, Vector Reduction, Antiviral Drugs — Progress In Prospect 1 Dec, 2010 Once-And-For-All TB Assay Brings Cheap, Sensitive, Specific, Seven-Day Diagnosis and Drug-Susceptibility Testing 15 Apr, 2007
- Previous story Ethnic lifestyle and diet differences have a big impact on health
- Next story Beyond Legs and Arms For Afghanistan: Disability A Resource Not A Liability
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014